Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
  4. Fast Track Articles
  5. Fast Track Article
image of An Insight into Research Advances on Herbal and Phytochemical Approaches to the Management of Hepatocellular Carcinoma from January 2020 to July 2024

Abstract

Background

Hepatocellular Carcinoma (HCC) is a primary hepatic tumor and is one of the world's third most frequent malignancies after lung and colorectal. After stomach, lung, and colorectal cancers, it is the most common cause of cancer-related mortality. Since the Palaeolithic era, herbs have been used as an essential source of alternative drugs. Modern cancer treatments that use chemotherapeutic medications are made of chemicals derived from plants.

Objective

The present review is about the compilation of phytochemical extracts and molecules from 2020 to July 2024.

Methods

A detailed literature survey was conducted to compile data from PubMed, Sci Finder, Science Direct, Google, .

Results

The identification of novel treatments and their combinations for usage in the adjuvant context potentially address significant unmet needs in the management of HCC. A large number of investigations have been carried out these days on plants. Numerous phytochemicals included in plant extract may possess anti-cancer properties, including the ability to induce cell cycle arrest, suppress cell proliferation, increase apoptosis, and obstruct migration, invasion, and metastasis. These approaches possess less hazardous and more effective treatment in HCC.

Conclusion

This article is the compilation of data about research on phytomolecules and herbal extracts from January 2020 to July 2024 for the treatment of HCC and . Various mechanisms involved in the treatment are also explored in the article. The growing interest of researchers in investigating new approaches toward HCC management with phytomolecules is rapidly growing. methods have been attempted in the past to characterize, research, and confront these extremely terrifying illness types. Numerous methodologies, including genetic, cellular, biochemical,

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/acamc/10.2174/0118715206348951241120120918
2025-01-13
2025-03-29

  • From This Site

    /content/journals/acamc/10.2174/0118715206348951241120120918
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Khan H.A. Isab A.A. Alhomida A.S. Gatasheh M.K. Alhoshani A.R. Aldhafeeri B.A. Prasad N.R. Synthesis of a Novel Gold(I) Complex and Evaluation of Its Anticancer Properties in Breast Cancer Cells. Anticancer. Agents Med. Chem. 2024 24 5 379 388 10.2174/0118715206281182231127113608 38305390
    [Google Scholar]
  2. Siegel R.L. Miller K.D. Jemal A. Cancer statistics, 2016. CA Cancer J. Clin. 2016 66 1 7 30 10.3322/caac.21332 26742998
    [Google Scholar]
  3. Anwar S. Almatroudi A. Alsahli M.A. Khan M.A. Khan A.A. Rahmani A.H. Natural Products: Implication in Cancer Prevention and Treatment through Modulating Various Biological Activities. Anticancer. Agents Med. Chem. 2020 20 17 2025 2040 10.2174/1871520620666200705220307 32628596
    [Google Scholar]
  4. Upadhyay A. Cancer: An unknown territory; rethinking before going ahead. Genes Dis. 2021 8 5 655 661 10.1016/j.gendis.2020.09.002 34291136
    [Google Scholar]
  5. Rahib L. Smith B.D. Aizenberg R. Rosenzweig A.B. Fleshman J.M. Matrisian L.M. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014 74 11 2913 2921 10.1158/0008‑5472.CAN‑14‑0155 24840647
    [Google Scholar]
  6. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona. ESMO Open. 2022 8 3 101567
    [Google Scholar]
  7. Samant H. Amiri H.S. Zibari G.B. Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management. J. Gastrointest. Oncol. 2021 12 S2 Suppl. 2 S361 S373 10.21037/jgo.2020.02.08 34422400
    [Google Scholar]
  8. Zhang C. Cheng Y. Zhang S. Fan J. Gao Q. Changing epidemiology of hepatocellular carcinoma in Asia. Liver Int. 2022 42 9 2029 2041 10.1111/liv.15251 35319165
    [Google Scholar]
  9. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. J. Liver Cancer 2023 23 1 1 120 10.17998/jlc.2022.11.07 37384024
    [Google Scholar]
  10. Giri S. Singh A. Epidemiology of Hepatocellular Carcinoma in India – An Updated Review for 2024. J. Clin. Exp. Hepatol. 2024 14 6 101447 10.1016/j.jceh.2024.101447 38957612
    [Google Scholar]
  11. Jung Y.Y. Kim C. Shanmugam M.K. Deivasigamani A. Chinnathambi A. Alharbi S.A. Rangappa K.S. Hui K.M. Sethi G. Mohan C.D. Ahn K.S. Leonurine ameliorates the STAT3 pathway through the upregulation of SHP-1 to retard the growth of hepatocellular carcinoma cells. Cell. Signal. 2024 114 111003 10.1016/j.cellsig.2023.111003 38048857
    [Google Scholar]
  12. Llovet J.M. Kelley R.K. Villanueva A. Singal A.G. Pikarsky E. Roayaie S. Lencioni R. Koike K. Zucman-Rossi J. Finn R.S. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 2021 7 1 6 10.1038/s41572‑020‑00240‑3 33479224
    [Google Scholar]
  13. Ho D.W.H. Lo R.C.L. Chan L.K. Ng I.O.L. Molecular Pathogenesis of Hepatocellular Carcinoma. Liver Cancer 2016 5 4 290 302 10.1159/000449340 27781201
    [Google Scholar]
  14. Liu B.J. Guan Y.Y. Qiao L.X. Zhang J.M. Li A.J. Yang P.X. Gao Y.X. Chen D.X. Wang C.X. Wu J. The mechanism and experimental verification of Ixeris sonchifolia promoting apoptosis of hepatocellular carcinoma based on network pharmacology. J. Ethnopharmacol. 2024 327 117994 10.1016/j.jep.2024.117994 38437889
    [Google Scholar]
  15. Tu H. Feng Y. Wang W. Zhou H. Cai Q. Feng Y. Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology. Chem. Biol. Drug Des. 2024 103 1 e14413 10.1111/cbdd.14413 38040415
    [Google Scholar]
  16. Huang J. Hao J. Nie J. Qian R. Li H. Zhao J. Wang Y. Possible Mechanism of Dysphania ambrosioides (L.) Mosyakin & Clemants Seed Extract Suppresses the Migration and Invasion of Human Hepatocellular Carcinoma Cells SMMC‐7721. Chem. Biodivers. 2023 20 3 e202200768 10.1002/cbdv.202200768 36694378
    [Google Scholar]
  17. Dwikat M. Amer J. Jaradat N. Salhab A. Rahim A.A. Qadi M. Aref A. Ghanim M. Murad H. Modallal A. Shalabni K. Arum palaestinum delays hepatocellular carcinoma proliferation through the PI3K-AKT-mTOR signaling pathway and exhibits anticoagulant effects with antimicrobial properties. Front. Pharmacol. 2023 14 1180262 10.3389/fphar.2023.1180262 37332348
    [Google Scholar]
  18. Dong W. Yang K.X. He X.F. Li T.Z. Chen J.J. New eudesmanolides from Artemisia verlotorum and their potential targets of hepatocellular carcinoma by network pharmacology. Fitoterapia 2023 167 105491 10.1016/j.fitote.2023.105491 37001826
    [Google Scholar]
  19. Fu C. Zhang Y. Xi W. Xu K. Meng F. Ma T. Li W. Wu L. Chen Z. Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway. J. Ethnopharmacol. 2023 308 116191 10.1016/j.jep.2023.116191 36731809
    [Google Scholar]
  20. Nasim N. Sandeep I.S. Mohanty S. Plant-derived natural products for drug discovery: current approaches and prospects. Nucleus 2022 65 3 399 411 10.1007/s13237‑022‑00405‑3 36276225
    [Google Scholar]
  21. Kesarwani K. Gupta R. Mukerjee A. Bioavailability enhancers of herbal origin: An overview. Asian Pac. J. Trop. Biomed. 2013 3 4 253 266 10.1016/S2221‑1691(13)60060‑X 23620848
    [Google Scholar]
  22. Yakubu O.F. Metibemu D.S. Adelani I.B. Adesina G.O. Edokwe C.B. Oseha O.E. Adebayo A.H. Annona senegalensis extract demonstrates anticancer properties in N-diethylnitrosamine-induced hepatocellular carcinoma in male Wistar rats. Biomed. Pharmacother. 2020 131 110786 10.1016/j.biopha.2020.110786 33152944
    [Google Scholar]
  23. Huang X.F. Chang K.F. Lee S.C. Sheu G.T. Li C.Y. Weng J.C. Hsiao C.Y. Tsai N.M. Extract Derived from Cedrus atlantica Acts as an Antitumor Agent on Hepatocellular Carcinoma Growth In Vitro and In Vivo. Molecules 2020 25 20 4608 10.3390/molecules25204608 33050385
    [Google Scholar]
  24. Guan Z. Chen J. Li X. Patrinia herba aqueous extract on the proliferation, apoptosis, invasion and migration of hepatocellular carcinoma cells. Cell. Mol. Biol. 2020 66 3 119 124 10.14715/cmb/2020.66.3.18 32538757
    [Google Scholar]
  25. Huang C.C. Hwang J.M. Tsai J.H. Chen J.H. Lin H. Lin G.J. Yang H.L. Liu J.Y. Yang C.Y. Ye J.C. Aqueous Ocimum gratissimum extract induces cell apoptosis in human hepatocellular carcinoma cells. Int. J. Med. Sci. 2020 17 3 338 346 10.7150/ijms.39436 32132869
    [Google Scholar]
  26. Wang R. Shao X. Yang J. Liu Z. Chew L. Shao Y. Ginkgo biloba Extract Mechanism Inhibits Hepatocellular Carcinoma through the Nuclear Factor-κB/p53 Signaling Pathway. J. Environ. Pathol. Toxicol. Oncol. 2020 39 2 179 189 10.1615/JEnvironPatholToxicolOncol.2020034510 32749126
    [Google Scholar]
  27. Huang X. Chen Y. Zhang X. Li F. Ye H. Extract of Stellera Chamaejasme L. Inhibits the Progression of Hepatocellular Carcinoma by Regulating miR-134-5p and JAK1/STAT3 Pathway. Cancer Biother. Radiopharm. 2020 35 8 586 595 10.1089/cbr.2019.3229 32486841
    [Google Scholar]
  28. Fang T. Zhao Z. Yuan F. He M. Sun J. Guo M. Huang P. Yang B. Xia J. Actinidia Chinensis Planch Root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting the DLX2/TARBP2/JNK/AKT pathway. J. Ethnopharmacol. 2020 251 112529 10.1016/j.jep.2019.112529 31891797
    [Google Scholar]
  29. Chen C. Ai Q. Wei Y. Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux. J. Ethnopharmacol. 2021 264 113388 10.1016/j.jep.2020.113388 32918990
    [Google Scholar]
  30. Munakarmi S. Chand L. Shin H. Hussein U. Yun B.S. Park H. Jeong Y. Anticancer effects of Poncirus fructus on hepatocellular carcinoma through regulation of apoptosis, migration, and invasion. Oncol. Rep. 2020 44 6 2537 2546 10.3892/or.2020.7790 33125135
    [Google Scholar]
  31. Thakur R.S. Devaraj E. Lagerstroemia speciosa (L.) Pers. triggers oxidative stress mediated apoptosis via intrinsic mitochondrial pathway in HEPG2 cells. Environ. Toxicol. 2020 35 11 1225 1233 10.1002/tox.22987 32697429
    [Google Scholar]
  32. Rohit Singh T. Ezhilarasan D. Ethanolic Extract of Lagerstroemia Speciosa (L.) Pers., Induces Apoptosis and Cell Cycle Arrest in HepG2 Cells. Nutr. Cancer 2020 72 1 146 156 10.1080/01635581.2019.1616780 31149840
    [Google Scholar]
  33. Cheng K.C. Wang C.J. Chang Y.C. Hung T.W. Lai C.J. Kuo C.W. Huang H.P. Mulberry fruits extracts induce apoptosis and autophagy of liver cancer cell and prevent hepatocarcinogenesis in vivo. Yao Wu Shi Pin Fen Xi 2020 28 1 84 93 10.38212/2224‑6614.1223 31883611
    [Google Scholar]
  34. Nguyen N.H. Ta Q.T.H. Pham Q.T. Luong T.N.H. Phung V.T. Duong T.H. Vo V.G. Anticancer Activity of Novel Plant Extracts and Compounds from Adenosma bracteosum (Bonati) in Human Lung and Liver Cancer Cells. Molecules 2020 25 12 2912 10.3390/molecules25122912 32599892
    [Google Scholar]
  35. Romualdo G.R. Silva E.A. Da Silva T.C. Aloia T.P.A. Nogueira M.S. De Castro I.A. Vinken M. Barbisan L.F. Cogliati B. Burdock (Arctium lappa L.) root attenuates preneoplastic lesion development in a diet and thioacetamide‐induced model of steatohepatitis‐associated hepatocarcinogenesis. Environ. Toxicol. 2020 35 4 518 527 10.1002/tox.22887 31804025
    [Google Scholar]
  36. Ishteyaque S. Mishra A. Mohapatra S. Singh A. Bhatta R.S. Tadigoppula N. Mugale M.N. In Vitro : Cytotoxicity, Apoptosis and Ameliorative Potential of Lawsonia inermis Extract in Human Lung, Colon and Liver Cancer Cell Line. Cancer Invest. 2020 38 8-9 476 485 10.1080/07357907.2020.1811300 32845783
    [Google Scholar]
  37. Mustafa K. Mohamed H. Shah A.M. Yu S. Akhlaq M. Xiao H. Li S. Naz T. Nosheen S. Bai X. Song Y. In Vitro Anticancer Potential of Berberis lycium Royle Extracts against Human Hepatocarcinoma (HepG2) Cells. BioMed Res. Int. 2020 2020 1 12 10.1155/2020/8256809 33110920
    [Google Scholar]
  38. Laparra Llopis J.M. Brown D. Saiz B. Chenopodium Quinoa and Salvia Hispanica Provide Immunonutritional Agonists to Ameliorate Hepatocarcinoma Severity under a High-Fat Diet. Nutrients 2020 12 7 1946 10.3390/nu12071946 32629893
    [Google Scholar]
  39. Lin X. Li K. Yang Z. Chen B. Zhang T. Dulcitol suppresses proliferation and migration of hepatocellular carcinoma via regulating SIRT1/p53 pathway. Phytomedicine 2020 66 153112 10.1016/j.phymed.2019.153112 31786318
    [Google Scholar]
  40. Liu B.J. Ning Q. Zhong R.L. Xia Z. Jiang Z.Y. Song J. Wei Y.J. Effect of lupeol on invasion and metastasis of human hepatoma HepG2 and SK-HEP-1 cells and its mechanism. Zhongguo Zhong Yao Za Zhi 2020 45 24 6028 6035 10.19540/j.cnki.cjcmm.20200901.403
    [Google Scholar]
  41. Okubo S. Ohta T. Fujita H. Shoyama Y. Uto T. Costunolide and dehydrocostuslactone from Saussurea lappa root inhibit autophagy in hepatocellular carcinoma cells. J. Nat. Med. 2021 75 1 240 245 10.1007/s11418‑020‑01462‑1 33159250
    [Google Scholar]
  42. Wang L. Li X. Zhou R. Shan Y. Effect of Bushen Jianpi formula on survival of patients with moderate and advanced hepatocellular carcinoma: a retrospective study. J. Tradit. Chin. Med. 2020 40 4 683 689 10.19852/j.cnki.jtcm.2020.04.018 32744036
    [Google Scholar]
  43. Wu J. Guo L. Qiu X. Ren Y. Li F. Cui W. Song S. Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation. Br. J. Cancer 2020 123 11 1673 1685 10.1038/s41416‑020‑01085‑z 32958824
    [Google Scholar]
  44. Liu S. Zhang J. Yang H. Zhang Q. Chen M. Pectolinarigenin flavonoid exhibits selective anti-proliferative activity in cisplatin-resistant hepatocellular carcinoma, autophagy activation, inhibiting cell migration and invasion, G2/M phase cell cycle arrest and targeting ERK1/2 MAP kinases. J. BUON 2020 25 1 415 420 32277663
    [Google Scholar]
  45. Tang Y. Cao J. Cai Z. An H. Li Y. Peng Y. Chen N. Luo A. Tao H. Li K. Epigallocatechin gallate induces chemopreventive effects on rats with diethylnitrosamine‑induced liver cancer via inhibition of cell division cycle 25A. Mol. Med. Rep. 2020 22 5 3873 3885 10.3892/mmr.2020.11463 33000276
    [Google Scholar]
  46. Zhan G. Hu J. Xiao B. Wang X. Yang Z. Yang G. Lu L. Trillin prevents proliferation and induces apoptosis through inhibiting STAT3 nuclear translocation in hepatoma carcinoma cells. Med. Oncol. 2020 37 5 44 10.1007/s12032‑020‑01369‑7 32270306
    [Google Scholar]
  47. Liao W. Liu X. Yang Q. Liu H. Liang B. Jiang J. Huang J. Ning C. Zang N. Zhou B. Liao Y. Chen J. Tian L. Ho W. Abdullah A.S. Kong L. Liang H. Chen H. Ye L. Deguelin inhibits HCV replication through suppressing cellular autophagy via down regulation of Beclin1 expression in human hepatoma cells. Antiviral Res. 2020 174 104704 10.1016/j.antiviral.2020.104704 31917237
    [Google Scholar]
  48. Abdel-Wahab A.H.A. Effat H. Mahrous E.A. Ali M.A. Al-Shafie T.A. A Licorice Roots Extract Induces Apoptosis and Cell Cycle Arrest and Improves Metabolism via Regulating MiRNAs in Liver Cancer Cells. Nutr. Cancer 2021 73 6 1047 1058 10.1080/01635581.2020.1783329 32578448
    [Google Scholar]
  49. Ads E.N. Abouzied A.S. Alshammari M.K. Evaluation of Cytotoxic Effects of Methanolic Extract of Pergularia tomentosa L Growing Wild in KSA. Asian Pac. J. Cancer Prev. 2021 22 S1 67 72 10.31557/APJCP.2021.22.S1.67 33576214
    [Google Scholar]
  50. Chen Y.S. Chang H.S. Hsiao H.H. Chen Y.F. Kuo Y.P. Yen F.L. Yen C.H. Identification of Beilschmiedia tsangii Root Extract as a Liver Cancer Cell–Normal Keratinocyte Dual-Selective NRF2 Regulator. Antioxidants 2021 10 4 544 10.3390/antiox10040544 33915987
    [Google Scholar]
  51. Alzahrani A.J. Potent antioxidant and anticancer activities of the methanolic extract of Calligonum comosum (L’Her) fruit hairs against human hepatocarcinoma cells. Saudi J. Biol. Sci. 2021 28 9 5283 5289 10.1016/j.sjbs.2021.05.053 34466106
    [Google Scholar]
  52. Alnuqaydan A.M. Rah B. Tamarix articulata Inhibits Cell Proliferation, Promotes Cell Death Mechanisms and Triggers G0/G1 Cell Cycle Arrest in Hepatocellular Carcinoma Cells. Food Technol. Biotechnol. 2021 59 2 162 173 10.17113/ftb.59.02.21.6904 34316277
    [Google Scholar]
  53. Huang N.C. Huang R.L. Huang X.F. Chang K.F. Lee C.J. Hsiao C.Y. Lee S.C. Tsai N.M. Evaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo. Biosci. Rep. 2021 41 7 BSR20211143 10.1042/BSR20211143 34151367
    [Google Scholar]
  54. Wang Q. Guan X. Lai C. Gao H. Zheng Y. Huang J. Lin B. Selenium enrichment improves anti-proliferative effect of oolong tea extract on human hepatoma HuH-7 cells. Food Chem. Toxicol. 2021 147 111873 10.1016/j.fct.2020.111873 33248145
    [Google Scholar]
  55. Thangavelu L. Geetha R.V. Devaraj E. Dua K. Chellappan D.K. Balusamy S.R. Acacia catechu seed extract provokes cytotoxicity via apoptosis by intrinsic pathway in HepG2 cells. Environ. Toxicol. 2022 37 3 446 456 10.1002/tox.23411 34800081
    [Google Scholar]
  56. Hooshmand S. Mahdinezhad M.R. Taraz Jamshidi S. Soukhtanloo M. Mirzavi F. Iranshahi M. Hasanpour M. Ghorbani A. Morus nigra L. extract prolongs survival of rats with hepatocellular carcinoma. Phytother. Res. 2021 35 6 3365 3376 10.1002/ptr.7056 33624311
    [Google Scholar]
  57. Chao W.W. Liou Y.J. Ma H.T. Chen Y.H. Chou S.T. Phytochemical composition and bioactive effects of ethyl acetate fraction extract (EAFE) of Glechoma hederacea L. J. Food Biochem. 2021 45 7 e13815 10.1111/jfbc.13815 34121206
    [Google Scholar]
  58. Chaudhry G.S. Sohimi N.K.A. Mohamad H. Zafar M.N. Ahmed A. Sung Y.Y. Muhammad T.S.T. Xylocarpus Moluccensis Induces Cytotoxicity in Human Hepatocellular Carcinoma HepG2 Cell Line via Activation of the Extrinsic Pathway. Asian Pac. J. Cancer Prev. 2021 22 S1 17 24 10.31557/APJCP.2021.22.S1.17 33576208
    [Google Scholar]
  59. Lenzi R.M. Campestrini L.H. Semprebon S.C. Paschoal J.A.R. Silva M.A.G. Zawadzki-Baggio S.F. Mantovani M.S. Petkowicz C.L.O. Maurer J.B.B. Glucosinolate-Enriched Fractions from Maca ( Lepidium meyenii ) Exert Myrosinase-Dependent Cytotoxic Effects against HepG2/C3A and HT29 Tumor Cell Lines. Nutr. Cancer 2022 74 4 1322 1337 10.1080/01635581.2021.1952444 34282687
    [Google Scholar]
  60. Kerdput V. Nilbu-nga C. Kaewnoonual N. Itharat A. Pongsawat S. Pradidarcheep W. Therapeutic efficacy of a Dioscorea membranacea extract in a rat model of hepatocellular carcinoma: Histopathological aspects. J. Tradit. Complement. Med. 2021 11 5 400 408 10.1016/j.jtcme.2021.02.001 34522634
    [Google Scholar]
  61. Rummun N. Serag A. Rondeau P. Ramsaha S. Bourdon E. Bahorun T. Farag M.A. Neergheen V.S. Antiproliferative activity of Syzygium coriaceum, an endemic plant of Mauritius, with its UPLC-MS metabolite fingerprint: A mechanistic study. PLoS One 2021 16 6 e0252276 10.1371/journal.pone.0252276 34061874
    [Google Scholar]
  62. Tuttis K. Costa D.L.M.G. Serpeloni J.M. Santos L.C. Varanda E.A. Vilegas W. Martínez-López W. Cólus I.M.S. Phytochemical Profile, and Antiproliferative and Proapoptotic Effects of Pouteria ramiflora (Mart.) Radlk. Leaf Extract, and Its Synergism with Cisplatin in HepG2 Cells. J. Med. Food 2021 24 5 452 463 10.1089/jmf.2020.0045 32757998
    [Google Scholar]
  63. Ansari S. Hasan K. Bhat S. Anticancer, antioxidant, and hepatoprotective activity of Saussurea lappa, C.B. clarke (qust) on human hepatoma cell line. J. Cancer Res. Ther. 2021 17 2 499 503 10.4103/jcrt.JCRT_571_19 34121698
    [Google Scholar]
  64. Alotaibi A.A. Bepari A. Assiri R.A. Niazi S.K. Nayaka S. Rudrappa M. Nagaraja S.K. Bhat M.P. Saussurea lappa Exhibits Anti-Oncogenic Effect in Hepatocellular Carcinoma, HepG2 Cancer Cell Line by Bcl-2 Mediated Apoptotic Pathway and Mitochondrial Cytochrome C Release. Curr. Issues Mol. Biol. 2021 43 2 1114 1132 10.3390/cimb43020079 34563048
    [Google Scholar]
  65. Yang P.W. Chen T.T. Zhao W.X. Liu G.W. Feng X.J. Wang S.M. Pan Y.C. Wang Q. Zhang S.H. Scutellaria barbata D.Don and Oldenlandia diffusa (Willd.) Roxb crude extracts inhibit hepatitis-B-virus-associated hepatocellular carcinoma growth through regulating circRNA expression. J. Ethnopharmacol. 2021 275 114110 10.1016/j.jep.2021.114110 33864890
    [Google Scholar]
  66. Li C. Pan X.Y. Ma M. Zhao J. Zhao F. Lv Y.P. Astragalus polysacharin inhibits hepatocellular carcinoma-like phenotypes in a murine HCC model through repression of M2 polarization of tumour-associated macrophages. Pharm. Biol. 2021 59 1 1531 1537 10.1080/13880209.2021.1991384 34726570
    [Google Scholar]
  67. Yazici Bektaş N. Ersoy E. Boğa M. Boran T. Çinar E. Özhan G. Gören A.C. Eroğlu Özkan E. Cytotoxic and apoptotic effects of Hypericum androsaemum on prostate adenocarcinoma (PC-3) and hepatocellular carcinoma (Hep G2) cell lines with identification of secondary metabolites by LC-HRMS. Turk. J. Chem. 2021 45 5 1621 1638 10.3906/kim‑2104‑17 34849072
    [Google Scholar]
  68. Badawy A. Hassanean H. Ibrahim A.K. Habib E.S. El-Magd M.A. Ahmed S.A. Isolates From Thymelaea Hirsuta Inhibit Progression Of Hepatocellular Carcinoma In Vitro And In Vivo. Nat. Prod. Res. 2021 35 11 1799 1807 10.1080/14786419.2019.1643859 31315443
    [Google Scholar]
  69. Fan B.B. Li T.J. Meng X.S. Wang S. Bao Y.R. Wang F. Mechanism of total glucosides from Chishao (Radix Paeoniae Rubra) on proliferation and apoptosis of hepatocellular carcinoma cells via phosphatase and tensin homolog deleted on chromosome ten / phosphatidylinositol 3-kinase / protein kinase B signaling pathway. J. Tradit. Chin. Med. 2021 41 5 677 683 10.19852/j.cnki.jtcm.2021.05.003 34708625
    [Google Scholar]
  70. Chang Z. Jian P. Zhang Q. Liang W. Zhou K. Hu Q. Liu Y. Liu R. Zhang L. Tannins in Terminalia bellirica inhibit hepatocellular carcinoma growth by regulating EGFR-signaling and tumor immunity. Food Funct. 2021 12 8 3720 3739 10.1039/D1FO00203A 33900343
    [Google Scholar]
  71. El-Hawary S.S. EL-Hefnawy H.M. Elemeery M.N. Osman S.M. EL-Raey M.A. Mokhtar F.A. Pan C.H. Ibrahim H.A. The role of active metabolites isolated from Jasminum multiflorum flowers against hepatitis C virus infection and related hepatocellular carcinoma. Nat. Prod. Res. 2022 36 10 2625 2629 10.1080/14786419.2021.1913588 33957828
    [Google Scholar]
  72. Ke W. Wang H. Zhao X. Lu Z. Foeniculum vulgare seed extract exerts anti-cancer effects on hepatocellular carcinoma. Food Funct. 2021 12 4 1482 1497 10.1039/D0FO02243H 33502415
    [Google Scholar]
  73. Pocasap P. Nonpunya A. Weerapreeyakul N. Pinus kesiya Royle ex Gordon induces apoptotic cell death in hepatocellular carcinoma HepG2 cell via intrinsic pathway by PARP and Topoisomerase I suppression. Biomed. Pharmacother. 2021 139 111628 10.1016/j.biopha.2021.111628 33940508
    [Google Scholar]
  74. Pasachan T. Duangjai A. Ontawong A. Amornlerdpison D. Jinakote M. Phatsara M. Soodvilai S. Srimaroeng C. Tiliacora triandra (Colebr.) Diels Leaf Aqueous Extract Inhibits Hepatic Glucose Production in HepG2 Cells and Type 2 Diabetic Rats. Molecules 2021 26 5 1239 10.3390/molecules26051239 33669133
    [Google Scholar]
  75. Aishwarya V. Solaipriya S. Sivaramakrishnan V. Role of ellagic acid for the prevention and treatment of liver diseases. Phytother. Res. 2021 35 6 2925 2944 10.1002/ptr.7001 33368795
    [Google Scholar]
  76. Yu M.H. Tsai M.C. Wang C.C. Wu S.W. Chang Y.J. Wu C.H. Wang C.J. Mulberry Leaf Polyphenol Extract and Rutin Induces Autophagy Regulated by p53 in Human Hepatoma HepG2 Cells. Pharmaceuticals (Basel) 2021 14 12 1310 10.3390/ph14121310 34959709
    [Google Scholar]
  77. Zhang M. Deng Y. Liu F. Zheng M. Liang Y. Sun W. Li Q. Li X.N. Qi C. Liu J. Chen C. Zhu H. Zhang Y. Five undescribed steroids from Talaromyces stipitatus and their cytotoxic activities against hepatoma cell lines. Phytochemistry 2021 189 112816 10.1016/j.phytochem.2021.112816 34087503
    [Google Scholar]
  78. Cho I.J. Kim J.K. Kim E.O. Park S.M. Kim S.C. Ki S.H. Ku S.K. Hemistepsin a Induces Apoptosis of Hepatocellular Carcinoma Cells by Downregulating STAT3. Int. J. Mol. Sci. 2021 22 9 4743 10.3390/ijms22094743 33947048
    [Google Scholar]
  79. Osman A. Salama A. Emam Mahmoud K. Sitohy M. Alleviation of carbon tetrachloride‐induced hepatocellular damage and oxidative stress in rats by Anabaena oryzae phycocyanin. J. Food Biochem. 2021 45 1 e13562 10.1111/jfbc.13562 33184842
    [Google Scholar]
  80. Yu X.Q. Yan Q.L. Shen S. Cheng Z.Y. Huang X.X. Yao G.D. Song S.J. Chamaejasmenin E from Stellera chamaejasme induces apoptosis of hepatocellular carcinoma cells by targeting c-Met in vitro and in vivo. Bioorg. Chem. 2022 119 105509 10.1016/j.bioorg.2021.105509 34844768
    [Google Scholar]
  81. Cho A.R. Park W.Y. Lee H.J. Sim D.Y. Im E. Park J.E. Ahn C.H. Shim B.S. Kim S.H. Antitumor Effect of Morusin via G1 Arrest and Antiglycolysis by AMPK Activation in Hepatocellular Cancer. Int. J. Mol. Sci. 2021 22 19 10619 10.3390/ijms221910619 34638959
    [Google Scholar]
  82. Shen J. Zhu X. Wu Z. Shi Y. Wen T. Uvangoletin, extracted from Sarcandra glabra, exerts anticancer activity by inducing autophagy and apoptosis and inhibiting invasion and migration on hepatocellular carcinoma cells. Phytomedicine 2022 94 153793 10.1016/j.phymed.2021.153793 34736000
    [Google Scholar]
  83. Zhang X. Bi C. Chen Q. Xu H. Shi H. Li X. Structure elucidation of arabinogalactoglucan isolated from Sedum sarmentosum Bunge and its inhibition on hepatocellular carcinoma cells in vitro. Int. J. Biol. Macromol. 2021 180 152 160 10.1016/j.ijbiomac.2021.03.051 33741368
    [Google Scholar]
  84. Yang T. Huo J. Xu R. Zhang Y. Synergistic effect of toosendanin and regorafenib against cell proliferation and migration by regulating WWOX signaling pathway in hepatocellular carcinoma. Phytother. Res. 2021 35 8 4567 4578 10.1002/ptr.7174 34058790
    [Google Scholar]
  85. Hasei S. Yamamotoya T. Nakatsu Y. Ohata Y. Itoga S. Nonaka Y. Matsunaga Y. Sakoda H. Fujishiro M. Kushiyama A. Asano T. Carnosic Acid and Carnosol Activate AMPK, Suppress Expressions of Gluconeogenic and Lipogenic Genes, and Inhibit Proliferation of HepG2 Cells. Int. J. Mol. Sci. 2021 22 8 4040 10.3390/ijms22084040 33919842
    [Google Scholar]
  86. Zein N. Elewa Y.H.A. Alruwaili M.K. Dewaard M. Alorabi M. Albogami S.M. Batiha G.E.S. Zahran M.H. Barhi date (Phoenix dactylifera) extract ameliorates hepatocellular carcinoma in male rats. Biomed. Pharmacother. 2022 156 113976 10.1016/j.biopha.2022.113976 36411668
    [Google Scholar]
  87. Okasha H. Aboushousha T. Coimbra M.A. Cardoso S.M. Ghareeb M.A. Metabolite Profiling of Alocasia gigantea Leaf Extract and Its Potential Anticancer Effect through Autophagy in Hepatocellular Carcinoma. Molecules 2022 27 23 8504 10.3390/molecules27238504 36500595
    [Google Scholar]
  88. Kanwal L. Ali S. Rasul A. Tahir H.M. Smilax china root extract as a novel Glucose- 6-phosphate dehydrogenase inhibitor for the treatment of hepatocellular carcinoma. Saudi J. Biol. Sci. 2022 29 10 103400 10.1016/j.sjbs.2022.103400 35991850
    [Google Scholar]
  89. Kerdput V. Kanjanapongkul K. Itharat A. Pramong R. Lamers W.H. Hakvoort T.B.M. Jongejan A. Pradidarcheep W. Molecular Changes Following Induction of Hepatocellular Carcinoma by Diethylnitrosamine and Thioacetamide, and Subsequent Treatment with Dioscorea membranacea Extract. Int. J. Med. Sci. 2022 19 12 1806 1815 10.7150/ijms.72987 36313224
    [Google Scholar]
  90. Ogar G.O. Minari J.B. Bello A.J. Chiwetalu J. Omogunwa O.E. Oshikoya O.S. Otaru M.T. Anyanele C.A. Influence of ethanolic extract of Allium sativum on TP53 gene and its anticancer potential in N-Nitrosodiethylamine (NDEA)-induced hepatocellular carcinoma in male albino rats. Iran. J. Basic Med. Sci. 2022 25 4 497 505 10.22038/IJBMS.2022.62295.13787 35656070
    [Google Scholar]
  91. Zheng Y. Su L. Tan J. Dong F. Actinidia chinensis Planch Root extract suppresses the growth and metastasis of hypopharyngeal carcinoma by inhibiting E2F Transcription Factor 1-mediated MNX1 antisense RNA 1. Bioengineered 2022 13 3 4911 4922 10.1080/21655979.2022.2037226 35152841
    [Google Scholar]
  92. Chen H-C. Altannavch N. Zhou X. Khan M.A. Ahmed A. Naranmandakh S. Fu J-J. Anti-oxidant and Anticancerous Effect of Fomitopsis officinalis (Vill. ex Fr. Bond. et Sing) Mushroom on Hepatocellular Carcinoma Cells In Vitro through NF-kB Pathway. Anticancer. Agents Med. Chem. 2022 22 8 1561 1570 10.2174/1871520621666210608101152 34102992
    [Google Scholar]
  93. Shekh R. Tiwari R.K. Ahmad A. Ahmad I. Alabdallah N.M. Saeed M. Ansari I.A. Mishra A. Ashfaque M. Bajpai P. Ethanolic extract of Coleus aromaticus leaves impedes the proliferation and instigates apoptotic cell death in liver cancer HepG2 cells through repressing JAK/STAT cascade. J. Food Biochem. 2022 46 10 e14368 10.1111/jfbc.14368 35945689
    [Google Scholar]
  94. Martínez M.J. Andreu A.B. Barbini L. Cytotoxic activity of Solanum tuberosum polyphenolic extracts in human hepatocarcinoma cells is mediated by apoptosis and autophagy. J. Food Sci. 2022 87 12 5303 5316 10.1111/1750‑3841.16366 36374216
    [Google Scholar]
  95. Zou X. Sui Y. Tang X.Y. Zhang R. Shu Q. Gong T. Wu S. Sun Z.W. Li W.L. Qu Z.Y. Mechanism of Bupleurum scorzonerifolium and Paeonia lactiflora herbal pair against liver cancer: an exploration based on UPLC-Q-TOF-MS combined with network pharmacology. Zhongguo Zhong Yao Za Zhi. 2022 47 13 3597 3608 10.19540/j.cnki.cjcmm.20220110.402
    [Google Scholar]
  96. Khalid H.R. Aamir M. Tabassum S. Alghamdi Y.S. Alzamami A. Ashfaq U.A. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of Solanum surattense against Hepatocellular Carcinoma. Molecules 2022 27 19 6220 10.3390/molecules27196220 36234758
    [Google Scholar]
  97. Rady H. Hassan A. Abd-Alla H. Abdel Raouf H. Salem S. Hemimycale Arabica Induced Non-Cytotoxic Anti-Migratory Activity in Hepatocellular Carcinoma In Vitro. Asian Pac. J. Cancer Prev. 2022 23 9 2921 2928 10.31557/APJCP.2022.23.9.2921 36172653
    [Google Scholar]
  98. Saqban L.H. Abdul Alamir Mezher Z. Hussain Ali I. Cytotoxic Effect of the Crude Alcoholic Extract of the Fruits of Citrullus Colocynthis on Human Hepatocyte Carcinoma (Hep-G2). Arch. Razi Inst. 2022 77 4 1389 1395 10.22092/ARI.2022.357807.2104 36883161
    [Google Scholar]
  99. Li S. Pei W. Yuan W. Yu D. Song H. Zhang H. Multi-omics joint analysis reveals the mechanism of action of the traditional Chinese medicine Marsdenia tenacissima (Roxb.) Moon in the treatment of hepatocellular carcinoma. J. Ethnopharmacol. 2022 293 115285 10.1016/j.jep.2022.115285 35429621
    [Google Scholar]
  100. Fagundes T.R. Taciane da Silva Bortoleti B. Tomiotto-Pellissier F. Concato V.M. Gonçalves M.D. Arakawa N.S. Miranda-Sapla M.M. Panis C. Pavanelli W.R. Grandiflorenic acid from Wedelia trilobata plant induces apoptosis and autophagy cell death in breast adenocarcinoma (MCF7), lung carcinoma (A549), and hepatocellular carcinoma (HuH7.5) cells lines. Toxicon 2022 217 112 120 10.1016/j.toxicon.2022.08.006 35995098
    [Google Scholar]
  101. Kumar P. Singh A.K. Verma P. Tiwari K.N. Mishra S.K. Network pharmacology-based study on apigenin present in the methanolic fraction of leaves extract of Cestrum nocturnum L. to uncover mechanism of action on hepatocellular carcinoma. Med. Oncol. 2022 39 10 155 10.1007/s12032‑022‑01759‑z 35852639
    [Google Scholar]
  102. Jiang J. Yang Z. Hou G. Yao X. Jiang J. The potential mechanism of Chebulae Fructus in the treatment of hepatocellular carcinoma on the basis of network pharmacology. Ann. Hepatol. 2022 27 4 100701 10.1016/j.aohep.2022.100701 35351639
    [Google Scholar]
  103. Wang H. Yu W. Zhang D. Zhao Y. Chen C. Zhu H. Cai E. Yan Z. Cytotoxic and anti-tumor effects of 3,4- seco -lupane triterpenoids from the leaves of Eleutherococcus sessiliflorus against hepatocellular carcinoma. Nat. Prod. Res. 2022 36 4 1062 1066 10.1080/14786419.2020.1844698 33183092
    [Google Scholar]
  104. Kumar A. Naithani M. Kumar N. Singh N. Agrawal S. Sharma A. Thapliyal S. Singh J. Handu S. Piperlongumine inhibits diethylnitrosamine induced hepatocellular carcinoma in rats. Hum. Exp. Toxicol. 2022 41 09603271211073593 10.1177/09603271211073593 35113675
    [Google Scholar]
  105. Puthongking P. Yongram C. Katekaew S. Sungthong B. Weerapreeyakul N. Dipterocarpol in Oleoresin of Dipterocarpus alatus Attributed to Cytotoxicity and Apoptosis-Inducing Effect. Molecules 2022 27 10 3187 10.3390/molecules27103187 35630669
    [Google Scholar]
  106. Gao Z. Ma W.J. Li T.Z. Ma Y.B. Hu J. Huang X.Y. Geng C.A. He X.F. Zhang X.M. Chen J.J. Artemidubolides A−T, cytotoxic unreported guaiane-type sesquiterpenoid dimers against three hepatoma cell lines from Artemisia dubia. Phytochemistry 2022 202 113299 10.1016/j.phytochem.2022.113299 35809862
    [Google Scholar]
  107. Zhang Y. Dong F. Cao Z. Wang T. Pan L. Luo W. Ding W. Li J. Jin L. Liu H. Zhang H. Mu J. Han M. Wei Y. Deng X. Liu D. Hao P. Zeng G. Pang Y. Liu G. Zhen C. Eupalinolide A induces autophagy via the ROS/ERK signaling pathway in hepatocellular carcinoma cells in vitro and in vivo. Int. J. Oncol. 2022 61 5 131 10.3892/ijo.2022.5421 36111510
    [Google Scholar]
  108. Li L. Xu H. Qu L. Xu K. Liu X. Daidzin inhibits hepatocellular carcinoma survival by interfering with the glycolytic/gluconeogenic pathway through downregulation of TPI1. Biofactors 2022 48 4 883 896 10.1002/biof.1826 35118741
    [Google Scholar]
  109. Gull N. Arshad F. Naikoo G.A. Hassan I.U. Pedram M.Z. Ahmad A. Aljabali A.A.A. Mishra V. Satija S. Charbe N. Negi P. Goyal R. Serrano-Aroca Á. Al Zoubi M.S. El-Tanani M. Tambuwala M.M. Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma. J. Gastrointest. Cancer 2023 54 2 368 390 10.1007/s12029‑022‑00809‑z 35285010
    [Google Scholar]
  110. Jae-Goo Kim Wooki Kim Ki-Young Kim Alpinia japonica extract induces apoptosis of hepatocellular carcinoma cells through G0/G1 cell cycle arrest and activation of JNK. Cell. Mol. Biol. 2023 69 2 12 18 10.14715/cmb/2023.69.2.3 37224052
    [Google Scholar]
  111. Tang X. Liu L. Li Y. Hao S. Zhao Y. Wu X. Li M. Chen Y. Deng S. Gou S. Cai D. Chen M. Li X. Sun Y. Gu L. Li W. Wang F. Zhang Z. Yao L. Shen J. Xiao Z. Du F. Chemical profiling and investigation of molecular mechanisms underlying anti-hepatocellular carcinoma activity of extracts from Polygonum perfoliatum L. Biomed. Pharmacother. 2023 166 115315 10.1016/j.biopha.2023.115315 37579693
    [Google Scholar]
  112. Gnocchi D. Sabbà C. Mazzocca A. Crithmum maritimum Improves Sorafenib Sensitivity by Decreasing Lactic Acid Fermentation and Inducing a Pro-Hepatocyte Marker Profile in Hepatocellular Carcinoma. Plant Foods Hum. Nutr. 2023 78 1 230 232 10.1007/s11130‑022‑01037‑3 36525173
    [Google Scholar]
  113. Bopape M. Tiloke C. Ntsapi C. Moringa oleifera and Autophagy: Evidence from In Vitro Studies on Chaperone-Mediated Autophagy in HepG 2 Cancer Cells. Nutr. Cancer 2023 75 10 1822 1847 10.1080/01635581.2023.2270215 37850743
    [Google Scholar]
  114. Bach T.S. La V.H. Khoi T.X. Nguyen D.H. Cuong C.B. Nguyen T.V. Identification, Phytochemistry and Biological Activities of Paris polyphylla on Hepatocellular Carcinoma. Pak. J. Biol. Sci. 2023 26 5 203 212 10.3923/pjbs.2023.203.212 37859552
    [Google Scholar]
  115. Kiran A. Altaf A. Sarwar M. Malik A. Maqbool T. Ali Q. Phytochemical profiling and cytotoxic potential of Arnebia nobilis root extracts against hepatocellular carcinoma using in-vitro and in-silico approaches. Sci. Rep. 2023 13 1 11376 10.1038/s41598‑023‑38517‑8 37452082
    [Google Scholar]
  116. Abdelrahim M.S. Abdel-Baky A.M. Bayoumi S.A.L. Mohamed S.M. Abdel-Mageed W.M. Backheet E.Y. Cytotoxic flavone-C-glycosides from the leaves of Dypsis pembana (H.E.Moore) Beentje & J.Dransf., Arecaceae: in vitro and molecular docking studies. BMC Complement. Med. Ther. 2023 23 1 214 10.1186/s12906‑023‑04046‑0 37391756
    [Google Scholar]
  117. Parvez M. Alhowiriny T. Al-Dosari M. Amina M. Rehman M.T. Al-Yousef H. Alanzi A. Alajmi M. Inhibition of hepatitis B virus activities by Rhazya stricta ‑derived acacetin and acetyl‑β‑carboline. Exp. Ther. Med. 2023 26 1 327 10.3892/etm.2023.12026 37346405
    [Google Scholar]
  118. Wang H. Liu Y. Cui J. Tong M. Guan W. Cao Z. Gao X. Han X. Xian X. Li J. Zhao L. Effects of Scutellaria strigillosa Hemsl. extract on HepG2 cell proliferation and apoptosis through binding to aspartate β-hydroxylase. Biochem. Biophys. Res. Commun. 2023 668 62 69 10.1016/j.bbrc.2023.05.077 37244036
    [Google Scholar]
  119. Bibi S. Nisar M. Rafique S. Waqas M. Zahoor M. Idrees M. Nazir N. Ihsan M. Salmen S.H. Alharbi S.A. Khan A. Al-Harrasi A. Harnessing Nature’s Gifts: Salix nigra and Its Potential for Combating Hepatitis C Virus (HCV). ACS Omega 2023 8 45 42987 42999 10.1021/acsomega.3c06193 38024752
    [Google Scholar]
  120. De Quadros A.P.O. Oshiiwa B. Petreanu M. Niero R. Rosa P.C.P. Sawaya A.C.H.F. Mantovani M.S. O’Neill De Mascarenhas Gaivão I. Maistro E.L. Rubus rosifolius (Rosaceae) stem extract induces cell injury and apoptosis in human hepatoma cell line. Toxicol. In Vitro 2023 86 105485 10.1016/j.tiv.2022.105485 36279965
    [Google Scholar]
  121. Vasarri M. Barletta E. Stio M. Bergonzi M.C. Galli A. Degl’Innocenti D. Ameliorative Effect of Posidonia oceanica on High Glucose-Related Stress in Human Hepatoma HepG2 Cells. Int. J. Mol. Sci. 2023 24 6 5203 10.3390/ijms24065203 36982278
    [Google Scholar]
  122. Hou Y. Zhao X. Wang Y. Li Y. Chen C. Zhou X. Jin J. Ye J. Li D. Gan L. Wu R. Oleuropein-Rich Jasminum Grandiflorum Flower Extract Regulates the LKB1-PGC-1α Axis Related to the Attenuation of Hepatocellular Lipid Dysmetabolism. Nutrients 2023 16 1 58 10.3390/nu16010058 38201888
    [Google Scholar]
  123. Sarkar S. Kar A. Shaw P. DasGupta B. Keithellakpam O.S. Mukherjee P.K. Bhardwaj P.K. Sharma N. Haldar P.K. Sinha S. Hydroalcoholic root extracts of Houttuynia cordata (Thunb.) standardized by UPLC-Q-TOF-MS/MS promotes apoptosis in human hepatocarcinoma cell HepG2 via GSK-3β/β-catenin/PDL-1 axis. Fitoterapia 2023 171 105684 10.1016/j.fitote.2023.105684 37751799
    [Google Scholar]
  124. Phucharoenrak P. Muangnoi C. Trachootham D. Metabolomic analysis of phytochemical compounds from ethanolic extract of lime (Citrus aurantifolia) peel and its anti-cancer effects against human hepatocellular carcinoma cells. Molecules 2023 28 7 2965 10.3390/molecules28072965 37049726
    [Google Scholar]
  125. Abdel-Bakky M.S. Mohammed H.A. Mahmoud N.I. Amin E. Alsharidah M. Al Rugaie O. Ewees M.G. Targeting the PI3K / pAKT / mTOR / NF‐κB / FOXO3a signaling pathway for suppressing the development of hepatocellular carcinoma in rats: Role of the natural remedic Suaeda vermiculata forssk. Environ. Toxicol. 2024 39 6 3666 3678 10.1002/tox.24217 38506534
    [Google Scholar]
  126. Luo J. Chen Q.X. Li P. Yu H. Yu L. Lu J.L. Yin H.Z. Huang B.J. Zhang S.J. Lobelia chinensis Lour inhibits the progression of hepatocellular carcinoma via the regulation of the PTEN/AKT signaling pathway in vivo and in vitro. J. Ethnopharmacol. 2024 318 Pt A 116886 10.1016/j.jep.2023.116886
    [Google Scholar]
  127. Waziri P. Auta R. Imam M.U. Chindo B.A. Ladan Z. Mohammed Z. Wayah S. Mohammed J. Tahir M.I. Ahmad A.E. Alhassan Y. Tyoapine D. Agbaji A.S. In vivo anti-hepatocellular carcinoma effects of the chloroform root extract of Clausena excavata Burm. J. Evid. Based Integr. Med. 2024 29 2515690X241251558 10.1177/2515690X241251558
    [Google Scholar]
  128. Wu T.H. Lin T.Y. Yang P.M. Li W.T. Yeh C.T. Pan T.L. Scutellaria baicalensis Induces Cell Apoptosis and Elicits Mesenchymal–Epithelial Transition to Alleviate Metastatic Hepatocellular Carcinoma via Modulating HSP90β. Int. J. Mol. Sci. 2024 25 5 3073 10.3390/ijms25053073 38474318
    [Google Scholar]
  129. Zhang F. Zhou K. Yuan W. Sun K. Radix Bupleuri-Radix Paeoniae Alba Inhibits the Development of Hepatocellular Carcinoma through Activation of the PTEN/PD-L1 Axis within the Immune Microenvironment. Nutr. Cancer 2024 76 1 63 79 10.1080/01635581.2023.2276525 37909316
    [Google Scholar]
  130. Ranatunge I. Soysa P. Polyphenol Mediated Suppression of Hepatocellular Carcinoma (HepG2) Cell Proliferation by Clerodendrum infortunatum L. Root. Asian Pac. J. Cancer Prev. 2024 25 1 351 363 10.31557/APJCP.2024.25.1.351 38285803
    [Google Scholar]
  131. Shaban N.Z. Hegazy W.A. Abu-Serie M.M. Talaat I.M. Awad O.M. Habashy N.H. Seedless black Vitis vinifera polyphenols suppress hepatocellular carcinoma in vitro and in vivo by targeting apoptosis, cancer stem cells, and proliferation. Biomed. Pharmacother. 2024 175 116638 10.1016/j.biopha.2024.116638 38688169
    [Google Scholar]
  132. Li N. Yang C. Xia J. Wang W. Xiong W. Molecular mechanisms of Codonopsis pilosula in inhibiting hepatocellular carcinoma growth and metastasis. Phytomedicine 2024 128 155338 10.1016/j.phymed.2024.155338 38520835
    [Google Scholar]
  133. Wang C. Zhang S. Li Y. Gong L. Yao C. Fu K. Li Y. Phillygenin Inhibits TGF-β1-induced Hepatic Stellate Cell Activation and Inflammation: Regulation of the Bax/Bcl-2 and Wnt/β-catenin Pathways. Inflammation 2024 47 4 1403 1422 Epub ahead of print 10.1007/s10753‑024‑01984‑w 38393550
    [Google Scholar]
  134. Zhu X.F. Sun Z.L. Ma J. Hu B. Yu M.C. Liu X.J. Yang P. Xu Y. Ju D. Mu Q. Synergistic anticancer effect of flavonoids from Sophora alopecuroides with Sorafenib against hepatocellular carcinoma. Phytother. Res. 2023 37 2 592 610 10.1002/ptr.7637 36180975
    [Google Scholar]
  135. Zhou X. Wu D. Mi T. Li R. Guo T. Li W. Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells. Chem. Biol. Interact. 2024 392 110926 10.1016/j.cbi.2024.110926 38431053
    [Google Scholar]
  136. Jiang K. Ning N. Huang J. Chang Y. Wang R. Ma J. Psilostachyin C reduces malignant properties of hepatocellular carcinoma cells by blocking CREBBP-mediated transcription of GATAD2B. Funct. Integr. Genomics 2024 24 2 75 10.1007/s10142‑024‑01353‑8 38600341
    [Google Scholar]
  137. Li C. Xie Y. Hu S. Yu H. Xu Y. Shen H. Yuan Y. Gu L. Pu B. Identification of formononetin as the active compound of CR‐SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co‐expression networks. Chem. Biol. Drug Des. 2024 103 1 e14363 10.1111/cbdd.14363 37793997
    [Google Scholar]
  138. Ma M.Y. Wang Q. Wang S.M. Feng X.J. Xian Z.H. Zhang S.H. Wogonin inhibits hepatoma cell proliferation by targeting miR‐27b‐5p/YWHAZ axis. J. Biochem. Mol. Toxicol. 2023 37 12 e23508 10.1002/jbt.23508 37623816
    [Google Scholar]
  139. Lai Q. Yang C.J. zhang Q. Zhuang M. Ma Y.H. Lin C.Y. Zeng G.Z. Yin J.L. Alkaloid from Alstonia yunnanensis diels root against gastrointestinal cancer: Acetoxytabernosine inhibits apoptosis in hepatocellular carcinoma cells. Front. Pharmacol. 2023 13 1085309 10.3389/fphar.2022.1085309 36712668
    [Google Scholar]
  140. Xie J. Wang H. Xie W. Liu Y. Chen Y. Gallic acid promotes ferroptosis in hepatocellular carcinoma via inactivating Wnt/β-catenin signaling pathway. Naunyn Schmiedebergs Arch. Pharmacol. 2024 397 4 2437 2445 10.1007/s00210‑023‑02770‑5 37847411
    [Google Scholar]
  141. Wang P. Cao J. Feng Z. Tang Y. Han X. Mao T. Li S. Guo Q. Ke X. Zhang X. Oroxylin a promoted apoptotic extracellular vesicles transfer of glycolytic kinases to remodel immune microenvironment in hepatocellular carcinoma model. Eur. J. Pharmacol. 2023 957 176037 10.1016/j.ejphar.2023.176037 37660969
    [Google Scholar]
  142. Qian Z. Feng N. Geng A. Tanshinone I suppresses hepatocellular carcinoma cells growth through targeting DNA double-strand break repair. Cancer Biol. Ther. 2023 24 1 2229958 10.1080/15384047.2023.2229958 37408176
    [Google Scholar]
  143. Li Q.Z. Chen Y.Y. Liu Q.P. Feng Z.H. Zhang L. Zhang H. Cucurbitacin B suppresses hepatocellular carcinoma progression through inducing DNA damage-dependent cell cycle arrest. Phytomedicine 2024 126 155177 10.1016/j.phymed.2023.155177 38412667
    [Google Scholar]
  144. Cheng Y. Zhan P. Lu J. Lu Y. Luo C. Cen X. Wang F. Xie C. Yin Z. Metformin synergistically enhances the antitumour activity of Lenvatinib in hepatocellular carcinoma by altering AKT‐FOXO3 signalling pathway. Liver Int. 2023 43 7 1577 1592 10.1111/liv.15611 37208925
    [Google Scholar]
  145. Liu Z. Wang N. Meng Z. Lu S. Peng G. Pseudolaric acid B triggers cell apoptosis by activating AMPK/JNK/DRP1/mitochondrial fission pathway in hepatocellular carcinoma. Toxicology 2023 493 153556 10.1016/j.tox.2023.153556 37244295
    [Google Scholar]
  146. Luo P. An Y. He J. Xing X. Zhang Q. Liu X. Chen Y. Yuan H. Chen J. Wong Y.K. Huang J. Gong Z. Du Q. Xiao W. Wang J. Icaritin with autophagy/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1/Parkin-mediated mitophagy in hepatocellular carcinoma. Cancer Lett. 2024 587 216621 10.1016/j.canlet.2024.216621 38242198
    [Google Scholar]
  147. Shan L. Zhao N. Wang F. Zhai D. Liu J. Lv X. Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation. J. Inflamm. Res. 2024 17 1589 1605 10.2147/JIR.S424384 38495344
    [Google Scholar]
  148. Tan J. Xiang Y. Xiong Y. Zhang Y. Qiao B. Zhang H. Crebanine induces ROS-dependent apoptosis in human hepatocellular carcinoma cells via the AKT/FoxO3a signaling pathway. Front. Pharmacol. 2023 14 1069093 10.3389/fphar.2023.1069093 36874025
    [Google Scholar]
  149. Jiang Z. Gao L. Liu C. Wang J. Han Y. Pan J. Sarmentosin Induces Autophagy-dependent Apoptosis via Activation of Nrf2 in Hepatocellular Carcinoma. J. Clin. Transl. Hepatol. 2023 10.14218/JCTH.2022.00312 37408810
    [Google Scholar]
  150. Xiao T. Bao J. Tian J. Lin R. Zhang Z. Zhu Y. He Y. Gao D. Sun R. Zhang F. Cheng Y. Shaletanati J. Zhou H. Xie C. Yang C. Flavokawain A suppresses the vasculogenic mimicry of HCC by inhibiting CXCL12 mediated EMT. Phytomedicine 2023 112 154687 10.1016/j.phymed.2023.154687 36804756
    [Google Scholar]
  151. Abusaliya A. Bhosale P.B. Kim H.H. Park M.Y. Jeong S.H. Lee S. Kim G.S. Investigation of prunetrin induced G2/M cell cycle arrest and apoptosis via Akt/mTOR/MAPK pathways in hepatocellular carcinoma cells. Biomed. Pharmacother. 2024 174 116483 10.1016/j.biopha.2024.116483 38552440
    [Google Scholar]
  152. Wang Y. Chen Y.Y. Gao G.B. Zheng Y.H. Yu N.N. Ouyang L. Gao X. Li N. Wen S.Y. Huang S. Zhao Q. Liu L. Cao M. Zhang S. Zhang J. He Q.Y. Polyphyllin D punctures hypertrophic lysosomes to reverse drug resistance of hepatocellular carcinoma by targeting acid sphingomyelinase. Mol. Ther. 2023 31 7 2169 2187 10.1016/j.ymthe.2023.05.015 37211762
    [Google Scholar]
  153. Xing Y. Zhong W. Peng D. Han Z. Zeng H. Wang Y. Feng L. Huang J. Xu L. Chen M. Zhou D. Jiang K. Deng X. Zhou H. Tong G. Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis/early cirrhosis in patients with chronic HBV infection: A multicenter, randomized clinical trial. Pharmacol. Res. 2023 190 106737 10.1016/j.phrs.2023.106737 36940891
    [Google Scholar]
  154. Guo B. Ruan Y. Wang Y. Xiao C. Zhong Z. Cheng B. Du J. Li B. Gu W. Yin Z. Jiedu Recipe, a compound Chinese herbal medicine, inhibits cancer stemness in hepatocellular carcinoma via Wnt/β-catenin pathway under hypoxia. J. Integr. Med. 2023 21 5 474 486 10.1016/j.joim.2023.06.008 37453868
    [Google Scholar]
  155. Duan Z.W. Liu Y. Zhang P.P. Hu J.Y. Mo Z.X. Liu W.Q. Ma X. Zhou X.H. Wang X.H. Hu X.H. Wei S.L. Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis. J. Ethnopharmacol. 2024 331 118293 10.1016/j.jep.2024.118293 38705430
    [Google Scholar]
  156. Li W. You L. Lin J. Zhang J. Zhou Z. Wang T. Wu Y. Zheng C. Gao Y. Kong X. Sun X. An herbal formula Shenlian decoction upregulates M1/M2 macrophage proportion in hepatocellular carcinoma by suppressing complement cascade. Biomed. Pharmacother. 2024 177 116943 Epub ahead of print 10.1016/j.biopha.2024.116943 38878636
    [Google Scholar]
  157. Wang M. Li Y. Li S. Wang T. Wang M. Wu H. Zhang M. Luo S. Zhao C. Li Q. Cheng H. Cinobufacini injection delays hepatocellular carcinoma progression by regulating lipid metabolism via SREBP1 signaling pathway and affecting macrophage polarization. J. Ethnopharmacol. 2024 321 117472 10.1016/j.jep.2023.117472 37995825
    [Google Scholar]
  158. Wang Y. Wang W. Liu K. Liu Y. Shen X. Li Q. Deng F. Hao X. Wang Y. The mechanism of Xihuang pills’ intervention in the tumour immune microenvironment for the treatment of liver cancer based on the STAT3-PDL1 pathway. J. Ethnopharmacol. 2024 331 118278 10.1016/j.jep.2024.118278 38710457
    [Google Scholar]
  159. Sun J. Ma M. Zhong X. Li J. Yi J. Zhang R. Liu X. Peng L. Sun X. Feng W. Hu R. Huang Q. Lv M. Fan K. Zhou X. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology. J. Ethnopharmacol. 2024 328 117985 10.1016/j.jep.2024.117985 38417600
    [Google Scholar]
  160. Wang F. Mai J. Wang H. Xu Y. Zhou X. Xie Z. Yu B. Liu P. Liu W. Cheng Y. Identification of Erzhu Jiedu Recipe and its molecular mechanism underlying inhibited human hepatoma cells by UHPLC-Q-Exactive Orbitrap HRMS and network pharmacology. J. Ethnopharmacol. 2024 325 117893 10.1016/j.jep.2024.117893 38336184
    [Google Scholar]
  161. Lin J. Wang S. Lan W. Ji M. Li M. Pien Tze Huang regulates phosphorylation of metabolic enzymes in mice of hepatocellular carcinoma. Sci. Rep. 2023 13 1 1897 10.1038/s41598‑023‑29116‑8 36732657
    [Google Scholar]
  162. Pei T. Dai Y. Tan X. Geng A. Li S. Gui Y. Hu C. An J. Yu X. Bao X. Wang D. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS2 technology. J. Ethnopharmacol. 2023 306 116134 10.1016/j.jep.2023.116134 36627003
    [Google Scholar]
  163. Chen C. Wu H. Fu X. Li R. Cheng H. Wang M. Zhou A. Zhang M. Li Q. A UPLC-QTOF/MS-based hepatic tissue metabolomics approach deciphers the mechanism of Huachansu tablets-based intervention against hepatocellular carcinoma. J. Pharm. Biomed. Anal. 2024 239 115875 10.1016/j.jpba.2023.115875 38061172
    [Google Scholar]
  164. Xing J. Tan R. Huang F. Tian N. Integrated analyses for identification of a three‐gene signature associated with Chaihu Shugan San formula for hepatocellular carcinoma treatment. J. Cell. Mol. Med. 2024 28 8 e18211 10.1111/jcmm.18211 38613352
    [Google Scholar]
  165. Liu Y. Li Y. Wang X. Huang Y. Zhang Q. Shi K. Ran C. Hou J. Wang X. Fufang Banmao Capsule, a Traditional Chinese Medicinal Formulation, Enhances the Survival of Patients with Hepatocellular Carcinoma and Vp3–4 Portal Vein Tumor Thrombosis Undergoing Supportive Treatment. J. Altern. Complement. Med. 2020 26 10 956 965 10.1089/acm.2019.0334 32614605
    [Google Scholar]
  166. Shen Y. Yang F. Peng H. Zhang G. Zhu F. Xu H. Shi L. Anti-tumor effect of Yanggan Huayu granule by inducing AKT-mediated apoptosis in hepatocellular carcinoma. J. Ethnopharmacol. 2022 282 114601 10.1016/j.jep.2021.114601 34487847
    [Google Scholar]
  167. Li X. Yu H. Gong Y. Wu P. Feng Q. Liu C. Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms. J. Ethnopharmacol. 2022 284 114801 10.1016/j.jep.2021.114801 34748868
    [Google Scholar]
  168. Li M. Shang H. Wang T. Yang S.Q. Li L. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing CCNB1 expression. World J. Gastroenterol. 2021 27 10 939 958 10.3748/wjg.v27.i10.939 33776365
    [Google Scholar]
  169. Zhou Z. Fu S. Li Y. Que Z. Liu X. Yu G. Gao D. Zhang Z. Wu T. Zhong Y. Molecular Mechanism of Bushen Jianpi Inhibition of Postoperative Recurrence and Metastasis of Hepatocellular Carcinoma. J. Biomed. Nanotechnol. 2021 17 1 53 63 10.1166/jbn.2021.3018 33653496
    [Google Scholar]
  170. Tang W. Xue J. Luo L. Wang Y. Cai X. Liu Y. Huang D. Wang X. He T. Lu D. Yang F. Kangxianruangan granule‑containing serum mediated inhibition of hepatic oval cell differentiation into hepatocellular carcinoma cells via the Wnt‑1/β‑catenin signaling pathway. Mol. Med. Rep. 2021 25 2 55 10.3892/mmr.2021.12571 34913065
    [Google Scholar]
  171. Toshida K. Itoh S. Yoshizumi T. Shimagaki T. Wang H. Kurihara T. Toshima T. Nagao Y. Harada N. Hata K. Makihara Y. Watanabe H. Mori M. Retrospective evaluation of the effect of Ninjin’yoeito in hepatocellular carcinoma patients treated with lenvatinib. Surg. Today 2022 52 3 441 448 10.1007/s00595‑021‑02358‑7 34417867
    [Google Scholar]
  172. Xu H. Wei W.Y.M. Dong C. Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis. Biosci Rep. 2020 40 1 BSR20194019 10.1042/BSR20194019
    [Google Scholar]
  173. Yang Y. Sun M. Li W. Liu C. Jiang Z. Gu P. Li J. Wang W. You R. Ba Q. Li X. Wang H. Rebalancing TGF‐β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis. Clin. Transl. Med. 2021 11 7 e410 10.1002/ctm2.410 34323416
    [Google Scholar]
  174. Yang X. Feng Y. Liu Y. Ye X. Ji X. Sun L. Gao F. Zhang Q. Li Y. Zhu B. Wang X. Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway. Phytomedicine 2021 87 153575 10.1016/j.phymed.2021.153575 33984593
    [Google Scholar]
  175. Ismail N. Abdel-Mottaleb Y. Eissa Ahmed A.A. El-Maraghy N.N. Novel combination of thymoquinone and resveratrol enhances anticancer effect on hepatocellular carcinoma cell line. Future J. Pharm. Sci. 2018 4 1 41 46 10.1016/j.fjps.2017.08.001
    [Google Scholar]
  176. Kavoosi F. Sanaei M. Pourahmadi M. Moosavi S. Effect of Genistein and 17-β Estradiol on the Viability and Apoptosis of Human Hepatocellular Carcinoma HepG2 cell line. Adv. Biomed. Res. 2017 6 1 163 10.4103/abr.abr_53_17 29387674
    [Google Scholar]
  177. Li Q. Li Y. Wang X. Fang X. He K. Guo X. Zhan Z. Sun C. Jin Y.H. Co‐treatment with ginsenoside Rh2 and betulinic acid synergistically induces apoptosis in human cancer cells in association with enhanced capsase‐8 activation, bax translocation, and cytochrome c release. Mol. Carcinog. 2011 50 10 760 769 10.1002/mc.20673 21751259
    [Google Scholar]
  178. Seydi E. Salimi A. Rasekh H.R. Mohsenifar Z. Pourahmad J. Selective Cytotoxicity of Luteolin and Kaempferol on Cancerous Hepatocytes Obtained from Rat Model of Hepatocellular Carcinoma: Involvement of ROS-Mediated Mitochondrial Targeting. Nutr. Cancer 2018 70 4 594 604 10.1080/01635581.2018.1460679 29693446
    [Google Scholar]
  179. Tong Y. Wang M. Huang H. Zhang J. Huang Y. Chen Y. Pan H. Inhibitory effects of genistein in combination with gefitinib on the hepatocellular carcinoma Hep3B cell line. Exp. Ther. Med. 2019 18 5 3793 3800 10.3892/etm.2019.8027 31611933
    [Google Scholar]
  180. Gu H.R. Park S.C. Choi S.J. Lee J.C. Kim Y.C. Han C.J. Kim J. Yang K.Y. Kim Y.J. Noh G.Y. No S.H. Jeong J.H. Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells. Clin. Mol. Hepatol. 2015 21 1 49 59 10.3350/cmh.2015.21.1.49 25834802
    [Google Scholar]
  181. Mao J. Yang H. Cui T. Pan P. Kabir N. Chen D. Ma J. Chen X. Chen Y. Yang Y. Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT. Eur. J. Pharmacol. 2018 832 39 49 10.1016/j.ejphar.2018.05.027 29782854
    [Google Scholar]
  182. Cheng Y. Zhao P. Wu S. Yang T. Chen Y. Zhang X. He C. Zheng C. Li K. Ma X. Xiang G. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. Int. J. Pharm. 2018 545 1-2 261 273 10.1016/j.ijpharm.2018.05.007 29730175
    [Google Scholar]
  183. Zhao X. Chen Q. Li Y. Tang H. Liu W. Yang X. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Eur. J. Pharm. Biopharm. 2015 93 27 36 10.1016/j.ejpb.2015.03.003 25770771
    [Google Scholar]
  184. Howells L.M. Berry D.P. Elliott P.J. Jacobson E.W. Hoffmann E. Hegarty B. Brown K. Steward W.P. Gescher A.J. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. Cancer Prev. Res. (Phila.) 2011 4 9 1419 1425 10.1158/1940‑6207.CAPR‑11‑0148 21680702
    [Google Scholar]
  185. Matsui Y. Uhara J. Satoi S. Kaibori M. Yamada H. Kitade H. Imamura A. Takai S. Kawaguchi Y. Kwon A.H. Kamiyama Y. Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study. J. Hepatol. 2002 37 1 78 86 10.1016/S0168‑8278(02)00091‑0 12076865
    [Google Scholar]
  186. Lintia-Gaultier A. Perret C. Ansquer C. Eugène T. Kraeber-Bodéré F. Frampas E. Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma. Nucl. Med. Commun. 2013 34 7 674 681 10.1097/MNM.0b013e32836141a0 23587835
    [Google Scholar]
  187. Tang C. Feng W. Qin L. Bao Y. Chinese Herbal Medicine, Jian Pi Li Gan Decoction, Improved Survival of Nonresectable Hepatocellular Cancer After Radiofrequency Ablation: A Retrospective Study. Integr. Cancer Ther. 2018 17 2 431 436 10.1177/1534735417722223 28745082
    [Google Scholar]
  188. Zhou B. Yan Z. Liu R. Shi P. Qian S. Qu X. Zhu L. Zhang W. Wang J. Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma. Radiology. 2016 280 2 630 639
    [Google Scholar]
  189. Chay W.Y. Tham C.K. Toh H.C. Lim H.Y. Tan C.K. Lim C. Wang W.W. Choo S.P. Coriolus versicolor (Yunzhi) Use as Therapy in Advanced Hepatocellular Carcinoma Patients with Poor Liver Function or Who Are Unfit for Standard Therapy. J. Altern. Compl. Med. 2017 23 8 648 652 10.1089/acm.2016.0136
    [Google Scholar]
  190. Cheng A.L. Kang Y.K. Chen Z. Tsao C.J. Qin S. Kim J.S. Luo R. Feng J. Ye S. Yang T.S. Xu J. Sun Y. Liang H. Liu J. Wang J. Tak W.Y. Pan H. Burock K. Zou J. Voliotis D. Guan Z. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009 10 1 25 34 10.1016/S1470‑2045(08)70285‑7 19095497
    [Google Scholar]
  191. Santoro A. Rimassa L. Borbath I. Daniele B. Salvagni S. Van Laethem J.L. Van Vlierberghe H. Trojan J. Kolligs F.T. Weiss A. Miles S. Gasbarrini A. Lencioni M. Cicalese L. Sherman M. Gridelli C. Buggisch P. Gerken G. Schmid R.M. Boni C. Personeni N. Hassoun Z. Abbadessa G. Schwartz B. Von Roemeling R. Lamar M.E. Chen Y. Porta C. Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study. Lancet Oncol. 2013 14 1 55 63 10.1016/S1470‑2045(12)70490‑4 23182627
    [Google Scholar]
/content/journals/acamc/10.2174/0118715206348951241120120918
Loading
An Insight into Research Advances on Herbal and Phytochemical Approaches to the Management of Hepatocellular Carcinoma from January 2020 to July 2024
Bentham Science Publishers ; https://doi.org/10.2174/0118715206348951241120120918
/content/journals/acamc/10.2174/0118715206348951241120120918
/content/journals/acamc/10.2174/0118715206348951241120120918
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: Hepatocellular carcinoma ; treatments ; in-vitroand in-vivo ; plant extract ; phytochemicals

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test